Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 11, 2023
Reporting Period: Second quarter ended June 30, 2023
This filing announces the issuance of a press release regarding the Company's financial results for the second quarter of 2023. A business update conference call was held on the date of the report.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing serves as a notification of the results rather than a detailed financial statement.
Material Changes
The filing text does not provide specific data to compare current period performance against the prior comparable period.
Guidance, Outlook, and Risks
Management Commentary: The Company held a conference call to discuss the business update and financial results.
Additional Information: Detailed materials are available on the Company's investor website (www.sanuwave.com/investors).
Legal Disclaimer: Information in Item 2.02 and attached exhibits is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific Q2 2023 financial figures.
- Access the investor relations website for the full business update materials and conference call details.
- Verify the Company's status as an emerging growth company (indicated as checked in the filing).
- Confirm the absence of registered securities on a national exchange (Trading Symbol listed as N/A).